Statute Details
- Title: National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012
- Act Code: NRDA2007-S410-2012
- Type: Subsidiary Legislation (sl)
- Authorising Act: National Registry of Diseases Act (Cap. 201B) — made under sections 6, 7 and 23
- Commencement: 1 September 2012
- Legislation Number: S 410/2012
- Status: Current version as at 27 Mar 2026 (per provided extract)
- Key Provisions: Regulation 1 (citation and commencement); Regulation 2 (definitions); Regulation 3 (form, time and manner of notification); Regulation 4 (collection of additional information)
- Schedules: First Schedule (information to be submitted); Second Schedule (forms/listings); Third Schedule (additional information)
What Is This Legislation About?
The National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012 (“AMIN Regulations”) create a mandatory notification framework for acute myocardial infarction (“acute MI”) cases to be reported to the National Registry of Diseases (“Registry”). In plain terms, when a patient is diagnosed with acute MI or is undergoing treatment for it, the manager of the relevant healthcare institution must notify the Registrar of the diagnosis and provide specified information.
The Regulations sit within Singapore’s broader National Registry of Diseases regime under the National Registry of Diseases Act (Cap. 201B). The Act establishes the Registry and empowers the Government to collect disease-related data for public health purposes, including monitoring disease incidence, supporting research, and informing healthcare planning. The AMIN Regulations operationalise those objectives for one particular condition—acute MI—by prescribing what counts as “acute MI”, how notifications must be made, and what additional information may be requested.
Practically, the Regulations are a compliance instrument: they translate the Act’s general notification powers into concrete administrative requirements for hospitals and other healthcare institutions. For lawyers advising healthcare providers, the key issues are (i) whether a case meets the definition of acute MI, (ii) what information must be submitted, (iii) the timing of notification, and (iv) the permissible channels and formats for submission, including secure electronic notification.
What Are the Key Provisions?
Regulation 1: Citation and commencement. This is a standard commencement provision. The Regulations may be cited as the National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012 and came into operation on 1 September 2012. For compliance purposes, the commencement date matters because the Regulations include transitional timing rules for patients already undergoing treatment at that time.
Regulation 2: Definitions—what counts as “acute myocardial infarction”. The definition is central because it determines when notification is triggered. “Acute myocardial infarction” is myocardial infarction with one or more specified clinical or diagnostic features, including:
- Cardiac biomarker changes beyond typical limits for the particular test, together with either symptoms indicative of myocardial ischaemia or electrocardiogram (ECG) changes indicative of new myocardial ischaemia;
- Development of new pathological Q waves in the patient’s ECG;
- New loss of viable myocardium or new regional wall motion abnormality;
- Fresh thrombus.
The definition also expressly includes acute MI developed as a complication of cardiovascular intervention for some other cardiac condition. This “complication” inclusion is important for clinical coding and case identification: even if the intervention was for a different cardiac issue, if acute MI results as a complication, notification may still be required.
Finally, “patient” is defined as the person to whom a notification under regulation 3 relates. While simple, it clarifies that the notification obligation is tied to individual patient cases.
Regulation 3: Form, time and manner of notification for acute myocardial infarction. This is the operative compliance provision. It addresses notifications “for the purposes of section 6(1) of the Act” and specifies that a notification by the manager of a healthcare institution to the Registrar must:
- Contain the information specified in the First Schedule;
- Be made in the appropriate Form or Listing specified in the Second Schedule. The extract indicates that the relevant form/listing may be downloaded from the Registry’s internet website (http://www.nrdo.gov.sg) or obtained from the Registry office during business hours;
- Be sent to the Registrar by one of the following methods:
- by hand (including by courier);
- by registered mail; or
- by using a secure electronic notification system approved by the Registrar.
Timing requirements are also specified in regulation 3(d), with three distinct scenarios:
- Where the patient has been diagnosed with acute MI: notification must be made not later than 3 months after the diagnosis was first made.
- Where the patient is undergoing treatment for acute MI that commenced before 1 September 2012 and continues on or after that date: notification must be made not later than 30 November 2012 (a transitional deadline).
- Where the patient is undergoing treatment for acute MI that commenced on or after 1 September 2012: notification must be made not later than 3 months after the treatment commenced.
For practitioners, the distinction between “diagnosed” and “undergoing treatment” is significant. In many clinical pathways, diagnosis and treatment commencement may occur close together, but they are not always identical. The Regulations therefore create two alternative triggers depending on the factual timeline: either diagnosis date (for diagnosed patients) or treatment commencement date (for patients already in treatment).
Regulation 4: Collection of additional information under section 7 of the Act. After a notification is received, the Registrar (or an authorised Registry officer) may require the manager of the healthcare institution to provide all or any of the additional information specified in the Third Schedule concerning the patient. This provision is a key enforcement and data-completeness mechanism. It means that initial notification under regulation 3 is not necessarily the end of the reporting process; further data may be demanded to support Registry purposes.
From a legal risk perspective, regulation 4 implies that healthcare institutions should maintain the ability to retrieve and verify patient-level clinical information promptly, because the Registrar’s request may be broad (“all or any”) and tied to the Third Schedule categories.
How Is This Legislation Structured?
The AMIN Regulations are structured in a straightforward regulatory format:
- Part/Regulation 1: Citation and commencement.
- Regulation 2: Definitions, including the detailed clinical definition of “acute myocardial infarction”.
- Regulation 3: The core notification rule—what must be included, what form/listing must be used, how it must be transmitted, and when it must be submitted.
- Regulation 4: Post-notification information supplementation—authorising the Registrar to require additional information under the Act.
- First Schedule: Information to be submitted with the notification.
- Second Schedule: Forms of notification (including the specific forms/listings to be used).
- Third Schedule: Additional information that may be requested by the Registrar.
Although the extract does not reproduce the contents of the schedules, the structure indicates a typical compliance design: the Regulations set the legal duties and timing, while the schedules operationalise the data fields and documentation formats.
Who Does This Legislation Apply To?
The Regulations apply to the manager of a healthcare institution who must notify the Registrar when a patient has been diagnosed with, or is undergoing treatment for, acute myocardial infarction at that institution. In practice, this typically includes hospitals and other clinical facilities that provide diagnosis and treatment and that fall within the Act’s definition of “healthcare institution” (as determined by the National Registry of Diseases Act and related interpretive provisions).
The obligation is triggered by the presence of acute MI in the patient’s clinical record and the institution’s role in diagnosis or treatment. The Regulations do not impose the duty on individual clinicians directly; rather, it is institutional and managerial, which is consistent with how reporting obligations are usually allocated in healthcare regulatory frameworks.
Why Is This Legislation Important?
For healthcare providers and their counsel, the AMIN Regulations are important because they create a time-bound statutory reporting obligation tied to a medically defined condition. Failure to notify within the prescribed period, or failure to submit the required information in the correct form and manner, can expose institutions to regulatory consequences under the National Registry of Diseases Act framework.
From a public health and governance perspective, the Regulations ensure that acute MI cases are captured in a consistent and standardised way. The detailed definition of acute MI (including biomarker/ECG criteria, pathological Q waves, imaging findings, and fresh thrombus) helps reduce ambiguity and supports data quality. The inclusion of acute MI as a complication of cardiovascular intervention further broadens capture to reflect real-world clinical pathways.
Finally, regulation 4’s additional information mechanism underscores that compliance is not merely “one submission and done”. The Registrar may require further patient-level data from the Third Schedule. Practically, institutions should implement internal processes—such as case identification protocols, audit trails, and data governance—to ensure that both initial notifications and subsequent information requests can be handled efficiently and accurately.
Related Legislation
- National Registry of Diseases Act (Cap. 201B) — the authorising Act, including sections 6, 7 and 23 referenced in the enacting formula
- National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012 — this subsidiary legislation (S 410/2012)
- National Registry of Diseases timeline / legislation versions — for confirming the correct version as at a relevant date (as indicated in the provided extract)
Source Documents
This article provides an overview of the National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.